Kura Oncology (KURA) Other Non Operating Income (2014 - 2021)

Kura Oncology (KURA) has 8 years of Other Non Operating Income data on file, last reported at $8000.0 in Q1 2021.

• Other Non Operating Income for Q1 2021 came in at $8000.0, down 46.67% year-over-year; the trailing twelve-month figure through Mar 2021 was $44000.0 (down 67.16% YoY), and the FY2020 annual result was $51000.0, down 79.18% from the prior year.
• Other Non Operating Income fell to $8000.0 in Q1 2021 per KURA's latest filing, from $12000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $195000.0 in Q1 2017 and troughed at $8000.0 in Q1 2021.
• A 5-year average of $107000.0 and a median of $126000.0 in 2019 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2017 and 2019: Other Non Operating Income changed 0.0% in 2017, then sank 92.22% in 2019.
• A 5-year view of Other Non Operating Income shows it stood at $195000.0 in 2017, then decreased by 7.69% to $180000.0 in 2018, then slumped by 92.22% to $14000.0 in 2019, then retreated by 14.29% to $12000.0 in 2020, then tumbled by 33.33% to $8000.0 in 2021.
• Business Quant data shows KURA's Other Non Operating Income at $8000.0 in Q1 2021, $12000.0 in Q4 2020, and $12000.0 in Q3 2020.